Evidence map›Paper›PMID 39194259›Full record

ArticleIUCrJ2024

From formulation to structure: 3D electron diffraction for the structure solution of a new indomethacin polymorph from an amorphous solid dispersion.

Helen W Leung, Royston C B Copley, Giulio I Lampronti, Sarah J Day, Lucy K Saunders, Duncan N Johnstone, Paul A Midgley

Abstract read
In one paragraph

Article in IUCrJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Helen W LeungDepartment of Materials Science and Metallurgy, University of Cambridge, 27 Charles Babbage Road, Cambridge CB3 0FS, United Kingdom.ORCID 0000-0002-5434-8673
Royston C B CopleyGSK R&D, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom.ORCID 0000-0002-8662-3895
Giulio I LamprontiDepartment of Materials Science and Metallurgy, University of Cambridge, 27 Charles Babbage Road, Cambridge CB3 0FS, United Kingdom.ORCID 0000-0002-1430-3446
Sarah J DayBeamline I11, Diamond Light Source, Didcot, Oxford OX11 0DE, United Kingdom.ORCID 0000-0003-1059-8475
Lucy K SaundersBeamline I11, Diamond Light Source, Didcot, Oxford OX11 0DE, United Kingdom.ORCID 0000-0001-5689-8129
Duncan N JohnstoneGSK R&D, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom.ORCID 0000-0003-3663-3793
Paul A MidgleyDepartment of Materials Science and Metallurgy, University of Cambridge, 27 Charles Babbage Road, Cambridge CB3 0FS, United Kingdom.ORCID 0000-0002-6817-458X

Funding

Diamond Light Source CY34800Engineering and Physical Sciences Research Council EP/R00879/1Wellcome Trust 210193
6 · The paper itself

Abstract

3D electron diffraction (3DED) is increasingly employed to determine molecular and crystal structures from micro-crystals. Indomethacin is a well known, marketed, small-molecule non-steroidal anti-inflammatory drug with eight known polymorphic forms, of which four structures have been elucidated to date. Using 3DED, we determined the structure of a new ninth polymorph, σ, found within an amorphous solid dispersion, a product formulation sometimes used for active pharmaceutical ingredients with poor aqueous solubility. Subsequently, we found that σ indomethacin can be produced from direct solvent evaporation using dichloromethane. These results demonstrate the relevance of 3DED within drug development to directly probe product formulations.

Indexed as

3D electron diffractionactive pharmaceutical ingredientsamorphous solid dispersionsdrug developmentindomethacinpharmaceutical formulationpolymorphismstructure determination

Identifiers

PMID39194259
PMCPMC11364028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.